Leprosy therapy, past and present: Can we hope to eliminate it?
Open Access
- 1 January 2010
- journal article
- research article
- Published by Medknow in Indian Journal of Dermatology
- Vol. 55 (4), 316-24
- https://doi.org/10.4103/0019-5154.74528
Abstract
Leprosy remains an important problem globally. Timely detection of new cases and prompt treatment with MDT continue to be the main intervention strategies. We review the various issues related to classification, treatment, drug resistance and the possible steps to eliminate the disease in the near future. The need for newer anti leprosy agents has been felt and various agents like fluroquinolones, macrolides and minocycline have all been tried in various combinations and duration. Uniform MDT in all leprosy patients might be a logical one too. Drug resistance can be identified by PCR based DNA sequence analysis which saves much time. Drugs like thalidomide analogues, pentoxifylline, selective cytokine inhibitory drugs have proved effective in controlling type-2 reaction in leprosy patients. New drugs for leprosy reactions are still needed. Far from being eliminated as a public health problem, leprosy still causes a considerable long term morbidity in both developing and developed world. New treatment and the optimal length of MDT requires further research. We need genome based technology to address the unresolved issues of transmission of M. leprae.Keywords
This publication has 58 references indexed in Scilit:
- Contact with armadillos increases the risk of leprosy in Brazil: A case control studyIndian Journal of Dermatology, Venereology and Leprology, 2008
- Methods for the Classification of Leprosy for Treatment PurposesClinical Infectious Diseases, 2007
- Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosyBrazilian Journal of Medical and Biological Research, 2007
- The Continuing Challenges of LeprosyClinical Microbiology Reviews, 2006
- MDT-MB therapy in paucibacillary leprosy: A clinicopathological assessmentIndian Journal of Dermatology, Venereology and Leprology, 2005
- ′Final push of leprosy′ in India: What is being pushed?Indian Journal of Dermatology, Venereology and Leprology, 2005
- Molecular Detection of Rifampin and Ofloxacin Resistance for Patients Who Experience Relapse of Multibacillary LeprosyClinical Infectious Diseases, 2002
- Multidrug Resistant Mycobacterium leprae from Patients with LeprosyAntimicrobial Agents and Chemotherapy, 2001
- Molecular basis of rifampin resistance in Mycobacterium lepraeAntimicrobial Agents and Chemotherapy, 1993
- The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.The Journal of Experimental Medicine, 1991